Trailing-twelve-month figures for context around the print.
Market cap
$143.6B
EPS (TTM)
$1.31
P/E (TTM)
19.2
price ÷ trailing earnings
Revenue growth
+1.4%
TTM vs a year ago
Gross margin
74.8%
of revenue kept after costs
Net margin
11.8%
of revenue kept as profit
52-week range
$23 – $29
now $25.25
Beta
0.28
steadier than the market
Dividend yield
6.81%
trailing twelve months
Estimates and reported figures via Finnhub; crowd odds are Pfizer Inc forecasts on Probs. Information, not investment advice.